{"description":"Nothing to mention","eventGroups":[{"deathsNumAffected":0,"deathsNumAtRisk":21,"description":"Patients receive filgrastim SC QD started at 24 hours after completion of chemotherapy and stopped when ANC reaches at least 1,000/uL post nadir.\n\nfilgrastim: Given SC once daily starting on day 1 after chemotherapy in Arm I (fixed) and on any day when ANC drops below 1000/mcl in Arm II (flexible)","id":"EG000","otherNumAffected":4,"otherNumAtRisk":21,"seriousNumAffected":0,"seriousNumAtRisk":21,"title":"Arm I (Fixed Filgrastim)"},{"deathsNumAffected":0,"deathsNumAtRisk":21,"description":"Patients receive filgrastim SC QD started on the first day after chemotherapy when ANC falls below 1,000/uL and stopped when ANC reaches at least 1,000/uL post nadir.\n\nfilgrastim: Given SC once daily starting on day 1 after chemotherapy in Arm I (fixed) and on any day when ANC drops below 1000/mcl in Arm II (flexible)","id":"EG001","otherNumAffected":1,"otherNumAtRisk":21,"seriousNumAffected":0,"seriousNumAtRisk":21,"title":"Arm II (Flexible Filgrastim)"}],"frequencyThreshold":"0","otherEvents":[{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","notes":"GCSF related pain (headaches, back or extremities pain)","organSystem":"Nervous system disorders","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":21,"numEvents":6},{"groupId":"EG001","numAffected":1,"numAtRisk":21,"numEvents":2}],"term":"Pain"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","notes":"GCSF related pain including headaches, back and extremities pain","organSystem":"Nervous system disorders","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":21,"numEvents":6},{"groupId":"EG001","numAffected":1,"numAtRisk":21,"numEvents":2}],"term":"Pain"}],"timeFrame":"6 months"}